- Home
- ORGO vs JQC Comparison
ORGO vs JQC Comparison
Compare ORGO & JQC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- JQC
- Stock Information
- Founded
- ORGO 1985
- JQC 2003
- Country
- ORGO United States
- JQC United States
- Employees
- ORGO N/A
- JQC N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- JQC Finance Companies
- Sector
- ORGO Health Care
- JQC Finance
- Exchange
- ORGO Nasdaq
- JQC Nasdaq
- Market Cap
- ORGO 620.3M
- JQC 718.4M
- IPO Year
- ORGO N/A
- JQC N/A
- Fundamental
- Price
- ORGO $4.10
- JQC $5.17
- Analyst Decision
- ORGO Buy
- JQC
- Analyst Count
- ORGO 3
- JQC 0
- Target Price
- ORGO $7.33
- JQC N/A
- AVG Volume (30 Days)
- ORGO 800.7K
- JQC 714.6K
- Earning Date
- ORGO 11-06-2025
- JQC 01-01-0001
- Dividend Yield
- ORGO N/A
- JQC 11.13%
- EPS Growth
- ORGO N/A
- JQC N/A
- EPS
- ORGO N/A
- JQC N/A
- Revenue
- ORGO $429,531,000.00
- JQC N/A
- Revenue This Year
- ORGO $2.51
- JQC N/A
- Revenue Next Year
- ORGO $25.45
- JQC N/A
- P/E Ratio
- ORGO N/A
- JQC N/A
- Revenue Growth
- ORGO N/A
- JQC N/A
- 52 Week Low
- ORGO $2.61
- JQC $4.82
- 52 Week High
- ORGO $6.71
- JQC $5.65
- Technical
- Relative Strength Index (RSI)
- ORGO 37.43
- JQC 30.21
- Support Level
- ORGO $4.12
- JQC $5.12
- Resistance Level
- ORGO $4.40
- JQC $5.35
- Average True Range (ATR)
- ORGO 0.24
- JQC 0.07
- MACD
- ORGO -0.06
- JQC -0.01
- Stochastic Oscillator
- ORGO 12.44
- JQC 21.15
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest
Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.